Browsing Tag
metastatic castration resistant prostate cancer
2 posts
What the LEGION-100 trial could mean for the future of combination immunotherapy strategies
Can the LEGION-100 trial redefine immunotherapy strategies? Explore what Syncromune Inc.’s approach means for oncology and future cancer treatments.
How next-generation masking strategies could reshape PSMA-directed T cell engager development
How Janux Therapeutics is advancing masked T cell engagers with JANX014. Find out what this means for prostate cancer treatment and immunotherapy.